跳至主要内容
临床试验/NCT00245648
NCT00245648已完成3 期

Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI; Results of the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries - V Trial

NYU Langone Health1 个研究点 分布在 1 个国家开始时间: 2001年6月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
1
主要终点
Primary Outcome

研究概览

简要总结

This study evaluated differences between men and women in the presentation, management and outcome of heart attacks within the GUSTO V study.

详细描述

The Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO) V trial examined a large, contemporary cohort of women and men with ST elevation myocardial infarction (STEMI) treated with fibrinolytic therapy. The objective of the present study was to evaluate sex differences in presentation, management and outcome in GUSTO V.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • inclusion into GUSTO V

排除标准

  • lack of availability of data (database study)

结局指标

主要结局

Primary Outcome

时间窗: 30 days

All cause mortality at 30 days after randomization.

次要结局

  • Secondary Outcomes(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Harmony R. Reynolds

Assistant Professor

NYU Langone Health

研究点 (1)

Loading locations...

相似试验